L2 - Dose Response Pt. 1

Ligand-Receptor Binding

• The fundamental concept of ligand-receptor binding outlines the interactions between a ligand (L) and a receptor (R) leading to the formation of a ligand-receptor complex (LR).

Modeling the Binding

• The model of ligand-receptor binding can be expressed as:

  • $L + R \rightleftharpoons LR$

  • The equation for the equilibrium dissociation constant (Kd) can be defined as:

  • $Kd = \frac{K<em>{off}}{K</em>{on}}$

    • where:

    • $K_{off}$ is the rate at which the ligand dissociates from the receptor.

    • $K_{on}$ is the rate at which the ligand binds to the receptor.

  • In terms of concentrations:

  • $Kd = \frac{[L][R]}{[LR]}$

  • Rearranging this gives:

  • $[LR] = \frac{[L][R]}{Kd}$

• The equilibrium dissociation constant (Kd) is a critical measure of the affinity of the ligand to the receptor.

Concentration Relationships

• The relationship among the ligand (L), receptors (R), and their complex (LR) is:

  • $[R_{0}] = [R] + [LR]$

  • This leads to:

  • $[LR] = \frac{[L][R_{0}]}{[L] + Kd}$

• There is a constant fractional occupancy of receptors defined as:

  • $\frac{[LR]}{[R_{0}]}$

Y-Axis Considerations

• The Y-axis represents two important values:

  • $[LR]$: the concentration of ligand-receptor complexes

  • $[R_{0}]$: total concentration of both occupied and unoccupied receptors

• The maximum value observed upon total receptor occupancy is 1.

• The graph of fractional occupancy typically utilizes a linear semi-logarithmic scale.

X-Axis Considerations

• The X-axis represents the concentration of ligand (L) across a wide range.

• Key points:

  • At equilibrium, when $[L] = Kd$, then:

  • $[LR] = \frac{K_{d}}{2}$

  • This means 50% receptor occupancy occurs at a concentration of $Kd$.

• Notably, a lower Kd indicates a tighter drug-receptor interaction.

  • Example: Drug A (lower Kd = 2 nM) binds more effectively than Drug B (Kd = 50 nM).

Case Study on Drug Binding

• Two investigational drugs targeting the same receptor involved in blood pressure regulation:

  • Drug A - Kd = 2 nM

  • Drug B - Kd = 50 nM

• Conclusion on receptor binding:

  • Correct Statement: C. Drug A has higher affinity because it binds the receptor at lower concentrations.

Dose Response I: Dose and Exposure

Drug-Receptor Interaction

• To understand drug-receptor interaction, substitute the ligand concentration [L] with:

  • [D]: concentration of free drug.

• This modifies the binding equation to:

  • $[LR] = \frac{[D][R_{0}]}{[D] + Kd}$

• The significance of high-affinity drugs (low Kd) is emphasized by their greater tendency to bind receptors.

Receptor Occupancy

• Example: Terazosin, used to treat hypertension and benign prostatic hypertrophy, acts as an antagonist at the alpha1-adrenergic receptor with Kd = 1 nM.

• Question to solve: Percentage of receptors occupied at various drug concentrations:

  • Concentration values: 0.5 nM, 1 nM, 4 nM, 10 nM.

Assumptions for Receptor Occupancy

• Drug response is proportional to the concentration of receptors occupied by the drug, where:

  • $\text{Response} \ (E) = [DR] = \frac{[D]}{[D] + Kd} \ \text{max response} \ (E<em>{max}) = \frac{[R</em>{0}]}{[D] + Kd}$

• The relationship indicates that increases in receptor occupancy will lead to increases in response, with a typical response effect observed across percentage ranges (0%, 25%, 50%, 75%, 100%).

Receptor Binding & Effects

• The receptor-mediated effects/responses are influenced by:

  • Properties of the ligand and its interactions.

  • Number of receptors present, including spare receptors.

  • Efficacy of signal transduction mechanisms.

Drug-Receptor Binding and Dose-Response Relationships

Key Definitions

• Dose: the amount of drug administered.

• Response: the resultant effect produced by a chemical on a biological system.

Conditions for Evaluating Dose-Response Relationships

• Response must be due to the administered chemical.

• The magnitude of response is correlated with the dose.

• There exists a target site for drug action.

• The relationship between dose and response is quantifiable.

Types of Dose-Response Curves

• Graded: Describes effects for individual responses.

• Quantal: Assesses responses of populations.

Graded Dose-Response Relationships

Graphical Representation

• Graded dose-response can be plotted:

  • Arithmetically

  • Semi-log scale

  • To determine the concentration that elicits a 50% response (EC50).

Potency and Efficacy

• Efficacy (Emax): maximal response produced by a drug.

• Potency: effective concentration (EC50) required for 50% of its maximal effect.

• A lower EC50 indicates higher potency and the relationship between the drug's effect and concentration levels allows comparison of therapeutic potential.

Case Study Interpretation

• Nopainol, an opioid analgesic, provides effective relief at low doses but not at maximal analgesic effect levels compared to morphine.

• Interpretation options:

  • The most accurate: C. Nopainol is more potent but less efficacious than morphine.

Spare Receptors and Maximal Effects

Spare Receptors Concept

• Spare receptors allow for maximal effect without full receptor occupancy.

• Without spare receptors, the biological effect directly correlates with receptor occupancy levels.

• With spare receptor presence, 50% response can be achieved with approximately 10% occupancy, reflecting efficient signal transduction.

Mechanisms Behind Spare Receptors

• Receptors may activate downstream signaling cascading effects even after ligand dissociation.

• Activation of a limited number of receptors can alone generate a maximal response due to signal amplification.

Quantal Dose-Response Relationships

Contextual Overview

• Assessing average drug effects on a population helps predict population-level responses to drug doses, informing dosage guidelines for therapeutic or toxic effects.

• Quantal curves indicate:

  • ED50: dose achieving therapeutic response in 50% of population.

  • TD50: toxic response in 50% of population.

  • LD50: lethal response in 50% of population.

Sensitivity and Variability

• Individual variability in response profiles plays a critical role in population sensitivity assessments:

  • Example: Comparing drugs A, B, and C under consistent statistical evaluations (log unit responses).

Therapeutics and Therapeutic Window

Therapeutic Index (TI)

• Defined as the ratio between the toxic dose and effective dose:

  • $TI = \frac{Toxic \ (Lethal) \ Dose<em>{50}}{Effective \ Dose</em>{50}}$

• A narrow therapeutic index is indicative of a drug with closely spaced effective and toxic doses, making it less safe.

Margin of Safety

• Margin = \frac{Toxic \ (Lethal) \ Dose{1}}{Effective \ Dose{99}}

• Preference for Margin of Safety over TI when evaluating non-parallel dose-response curves.

Case Study for Comparative Analysis of Drug Safety

• Involves comparing two analgesic drugs based on their ED50 and TD50 to infer safety profiles:

  • Drug A: ED50 = 10 mg; TD50 = 100 mg

  • Drug B: ED50 = 20 mg; TD50 = 60 mg

• Correct Analysis: B. Drug A has a larger therapeutic index and is safer.